NCT03800446

Brief Summary

Measurement of iron is important for identifying both low and high iron levels in the body. Measuring a protein in the blood called ferritin is currently the easiest way to determine a patient's iron status. However, the test requires a blood sample that is be sent to the laboratory for measurement, which can cause delays in obtaining the result. The investigators are testing whether a point of care device that measures ferritin levels using a capillary blood sample is accurate compared to current methods of testing. This could allow measurement of ferritin immediately in the clinic with only a drop of blood, and enable treatment decisions based on these results.

Trial Health

15
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Timeline
Completed

Started Sep 2019

Shorter than P25 for not_applicable

Status
withdrawn

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 12, 2018

Completed
1 month until next milestone

First Posted

Study publicly available on registry

January 11, 2019

Completed
8 months until next milestone

Study Start

First participant enrolled

September 1, 2019

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2020

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2020

Completed
Last Updated

December 19, 2019

Status Verified

December 1, 2019

Enrollment Period

7 months

First QC Date

December 12, 2018

Last Update Submit

December 17, 2019

Conditions

Outcome Measures

Primary Outcomes (1)

  • Point of care ferritin detection accuracy

    The proportion of subjects where the difference between the two different methods is less than 15; this will be measured by calculating the difference between the two results. The proportion for the absolute difference between the two measurement methods on the same subject that is less than 15 ng/mL will be calculated. Non-inferiority test for one proportion will be performed to examine, if, the proportion is greater than 95%, where the test p value and the one-sided 97.5% confidence interval will be reported. An interim analysis will be performed after the first 50 subjects are enrolled to test the assumptions made.

    Within 12 hours of standard testing

Secondary Outcomes (4)

  • Distribution of the differences between ferritin level as measured by the standard test and POC test

    Within 12 hours of standard testing

  • Comparison of the differences between ferritin levels as measured by the standard test and POC test in a Repeated Measures Design

    Within 12 hours of standard testing

  • Agreement between testing methods in patients who have been assessed at least twice

    Within 12 hours of standard testing

  • Diagnostic accuracy of the new measurement method

    Within 12 hours of standard testing

Study Arms (1)

Intervention

OTHER

All patients will undergo testing with the study intervention (point of care) and routine testing with serum ferritin (venous blood sample).

Diagnostic Test: Point of care ferritin test

Interventions

Point of care test that uses capillary blood sample from finger to determine ferritin level

Intervention

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • able to read and understand English (the consent form is in English)
  • attending ambulatory hematology clinic and/or outpatient medical care

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Anemia, Iron-DeficiencyIron Overload

Condition Hierarchy (Ancestors)

Anemia, HypochromicAnemiaHematologic DiseasesHemic and Lymphatic DiseasesIron DeficienciesIron Metabolism DisordersMetabolic DiseasesNutritional and Metabolic Diseases
0

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
SINGLE GROUP
Model Details: Prospective cohort diagnostic study design
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor; Department of Medicine, Director Operations; Hamilton Regional Laboratory Medicine Program

Study Record Dates

First Submitted

December 12, 2018

First Posted

January 11, 2019

Study Start

September 1, 2019

Primary Completion

April 1, 2020

Study Completion

June 1, 2020

Last Updated

December 19, 2019

Record last verified: 2019-12

Data Sharing

IPD Sharing
Will not share